Audrey Ardern‐Jones

7.1k total citations
48 papers, 2.1k citations indexed

About

Audrey Ardern‐Jones is a scholar working on Genetics, Sociology and Political Science and Molecular Biology. According to data from OpenAlex, Audrey Ardern‐Jones has authored 48 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Genetics, 13 papers in Sociology and Political Science and 12 papers in Molecular Biology. Recurrent topics in Audrey Ardern‐Jones's work include BRCA gene mutations in cancer (32 papers), Family Support in Illness (11 papers) and Genetic factors in colorectal cancer (9 papers). Audrey Ardern‐Jones is often cited by papers focused on BRCA gene mutations in cancer (32 papers), Family Support in Illness (11 papers) and Genetic factors in colorectal cancer (9 papers). Audrey Ardern‐Jones collaborates with scholars based in United Kingdom, United States and Canada. Audrey Ardern‐Jones's co-authors include Rosalind A. Eeles, Claire Foster, Maggie Watson, Regina H. Kenen, Nina Hallowell, Clare Moynihan, Elizabeth Bancroft, Susan Shanley, Victoria Murday and Christian Rothermundt and has published in prestigious journals such as Journal of Clinical Oncology, Social Science & Medicine and British Journal of Cancer.

In The Last Decade

Audrey Ardern‐Jones

48 papers receiving 2.1k citations

Peers

Countries citing papers authored by Audrey Ardern‐Jones

Since Specialization

Citations

This map shows the geographic impact of Audrey Ardern‐Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey Ardern‐Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey Ardern‐Jones more than expected).

Fields of papers citing papers by Audrey Ardern‐Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey Ardern‐Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey Ardern‐Jones. The network helps show where Audrey Ardern‐Jones may publish in the future.

Co-authorship network of co-authors of Audrey Ardern‐Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey Ardern‐Jones. A scholar is included among the top collaborators of Audrey Ardern‐Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey Ardern‐Jones. Audrey Ardern‐Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	“It’s all very well reading the letters in the genome, but it’s a long way to being able to write”: Men’s interpretations of undergoing genetic profiling to determine future risk of prostate cancer 2014 ·Familial Cancer ·Elizabeth Bancroft, Elena Castro, Audrey Ardern‐Jones, Clare Moynihan, Elizabeth Page, Natalie Taylor, Rosalind A. Eeles, Emma Rowley, Karen Cox	15
2	Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening tests 2011 ·Hereditary Cancer in Clinical Practice ·Marielle Nobbenhuis, Elizabeth Bancroft, Eleanor Moskovic, (unknown), Paul D.P. Pharoah, Ian Jacobs, Ann Ward, (unknown), Thomas Ind, John H. Shepherd, Jane Bridges, Martin Gore, (unknown), Susan Shanley, Audrey Ardern‐Jones, Sarah Thomas, Rosalind A. Eeles	5
3	Ownership of Uncertainty: Healthcare Professionals Counseling and Treating Women from Hereditary Breast and Ovarian Cancer Families Who Receive an Inconclusive BRCA1/2 Genetic Test Result 2011 ·Genetic Testing and Molecular Biomarkers ·Regina H. Kenen, Audrey Ardern‐Jones, Elly Lynch, Rosalind A. Eeles	10
4	The carrier clinic: an evaluation of a novel clinic dedicated to the follow-up of BRCA1 and BRCA2 carriers—implications for oncogenetics practice 2010 ·Journal of Medical Genetics ·Elizabeth Bancroft, Imogen Locke, Audrey Ardern‐Jones, (unknown), (unknown), (unknown), Yolanda Barbáchano, Julian Barwell, Lyndon Walker, Geraldine M. Mitchell, Huw Dorkins, (unknown), J. Paterson, (unknown), Anita Mitra, Sameer Jhavar, (unknown), Richard S. Houlston, Susan Shanley, Rosalind A. Eeles	11
5	Unusual presentation of Lynch Syndrome 2009 ·Hereditary Cancer in Clinical Practice ·Veronica Yu, Marco Novelli, Stewart J. Payne, (unknown), Rebecca A. Barnetson, Ian M. Frayling, Ann Barrett, David Goudie, Audrey Ardern‐Jones, Rosalind A. Eeles, Susan Shanley	13
6	Communicating genetics research results to families: problems arising when the patient participant is deceased 2008 ·Psycho-Oncology ·Elizabeth Ormondroyd, Clare Moynihan, Audrey Ardern‐Jones, Rosalind A. Eeles, Claire Foster, (unknown), Maggie Watson	15
7	Association between hormonal genetic polymorphisms and early-onset prostate cancer 2005 ·Prostate Cancer and Prostatic Diseases ·Matthew S. Forrest, S M Edwards, Richard S. Houlston, Zsofia Kote‐Jarai, Timothy J. Key, Naomi E. Allen, Margaret A. Knowles, Faye Turner, Audrey Ardern‐Jones, (unknown), Sue Williams, Richard A. Oram, (unknown), D. Timothy Bishop, Rosalind A. Eeles	46
8	Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40 2005 ·European Journal of Cancer Care ·Audrey Ardern‐Jones, Regina H. Kenen, Rosalind A. Eeles	67
9	Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers 2005 ·British Journal of Cancer ·Zsofia Kote‐Jarai, Asher Salmon, (unknown), Michelle Copeland, Audrey Ardern‐Jones, Imogen Locke, Susan Shanley, Brenda Summersgill, Yong‐Jie Lu, Janet Shipley, Rosalind A. Eeles	28
10	Developments in Clinical Practice: Follow up Clinic for BRCA Mutation Carriers: a Case Study Highlighting the "Virtual Clinic" 2004 ·Hereditary Cancer in Clinical Practice ·Audrey Ardern‐Jones, Rosalind A. Eeles	6
11	ATM polymorphisms as risk factors for prostate cancer development 2004 ·British Journal of Cancer ·Sandra Angèle, Alison Falconer, S M Edwards, Thilo Dörk, M. Bremer, Norman Moullan, Brigitte Chapot, Kenneth Muir, Richard S. Houlston, A. Norman, Sarah Bullock, (unknown), J.C. Meitz-Hopkins, David Dearnaley, Anna Dowe, Christine Southgate, Audrey Ardern‐Jones, Douglas F. Easton, Rosalind A. Eeles, J. Hall	75
12	Association between leptin receptor gene polymorphisms and early‐onset prostate cancer 2003 ·British Journal of Urology ·Zsofia Kote‐Jarai, (unknown), Francine Durocher, Douglas F. Easton, Stephen M. Edwards, Audrey Ardern‐Jones, David Dearnaley, Richard S. Houlston, Roger Kirby, Rosalind A. Eeles	23
13	Apoptosis, ageing and cancer susceptibility 2003 ·British Journal of Cancer ·Richard S. Camplejohn, R Gilchrist, Douglas F. Easton, (unknown), D M Barnes, Diana Eccles, Audrey Ardern‐Jones, SV Hodgson, (unknown), Rosalind A. Eeles	31
14	Genetic Testing for Women Previously Diagnosed with Breast/Ovarian Cancer: Examining the Impact of BRCA1 and BRCA2 Mutation Searching 2002 ·Genetic Testing ·Nina Hallowell, Claire Foster, Audrey Ardern‐Jones, Rosalind A. Eeles, Victoria Murday, Maggie Watson	69
15	Cancer genes - Management of carriers of breast cancer genes who have already developed cancer: the Carrier Clinic Model 2002 ·European Journal of Cancer Care ·Audrey Ardern‐Jones, Rosalind A. Eeles	2
16	Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer 2001 ·Pharmacogenetics ·(unknown), Douglas Easton, Steven M. Edwards, Sarah Jefferies, Francine Durocher, (unknown), Rashmi Singh, Audrey Ardern‐Jones, (unknown), David Dearnaley, Robert Shearer, Roger Kirby, Richard S. Houlston, Rosalind A. Eeles	76
17	Androgen receptor polymorphisms: Association with prostate cancer risk, relapse and overall survival 1999 ·International Journal of Cancer ·Stephen M. Edwards, (unknown), Ralph Minter, Rifat Hamoudi, Nadine Collins, Audrey Ardern‐Jones, Anna Dowe, Simon A. Osborne, Jo A. Kelly, Robert Shearer, Doug Easton, Grady F. Saunders, David P. Dearnaley, Rosalind A. Eeles	121
18	Immunohistochemical expression of BRCA2 protein and allelic loss at theBRCA2 locus in prostate cancer 1998 ·International Journal of Cancer ·Stephen M. Edwards, W.D. Dunsmuir, Cheryl Gillett, Sunil R. Lakhani, Catherine M. Corbishley, Martin E. Young, Roger Kirby, D.P. Dearnaley, Anna Dowe, Audrey Ardern‐Jones, Jo A. Kelly, (unknown), Nigel K. Spurr, (unknown), Rosalind A. Eeles	26
19	Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1 1998 ·British Journal of Cancer ·(unknown), W.D. Dunsmuir, Steve Edwards, Sunil R. Lakhani, Martin Young, Cathy Corbishley, Roger Kirby, (unknown), Anna Dowe, Audrey Ardern‐Jones, Jo A. Kelly, Rosalind A. Eeles	21
20	No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters 1997 ·British Journal of Cancer ·(unknown), (unknown), (unknown), Audrey Ardern‐Jones, Rifat Hamoudi, DF Easton, Deborah Ford, Robert Shearer, Anna Dowe, Rosalind A. Eeles	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact